Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 907

1.

Vegetables and Mixed Dishes Are Top Contributors to Phylloquinone Intake in US Adults: Data from the 2011-2012 NHANES.

Harshman SG, Finnan EG, Barger KJ, Bailey RL, Haytowitz DB, Gilhooly CH, Booth SL.

J Nutr. 2017 May 31. pii: jn248179. doi: 10.3945/jn.117.248179. [Epub ahead of print]

PMID:
28566528
2.

Benefits of once-daily dosing with non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

Amara W, Antoniou S.

Eur Heart J Suppl. 2016 Apr 20;18(Suppl D):D1-D6. doi: 10.1093/eurheartj/suv062. Epub 2016 Apr 21.

3.

Aprepitant and fosaprepitant drug interactions: a systematic review.

Patel P, Leeder JS, Piquette-Miller M, Dupuis LL.

Br J Clin Pharmacol. 2017 May 4. doi: 10.1111/bcp.13322. [Epub ahead of print]

PMID:
28470980
4.

The Use of 3- and 4-Factor Prothrombin Complex Concentrate in Patients With Elevated INR.

Mohan S, Howland MA, Lugassy D, Jacobson J, Su MK.

J Pharm Pract. 2017 Jan 1:897190017707119. doi: 10.1177/0897190017707119. [Epub ahead of print]

PMID:
28468525
5.

Dabigatran Compared With Rivaroxaban vs Warfarin-Reply.

Graham DJ, Wernecke M, Kelman JA.

JAMA Intern Med. 2017 May 1;177(5):743-744. doi: 10.1001/jamainternmed.2017.0567. No abstract available.

PMID:
28460105
6.

Photolysis of pharmaceuticals and personal care products in the marine environment under simulated sunlight conditions: irradiation and identification.

Ali AMM, Kallenborn R, Sydnes LK, Rønning HT, Alarif WM, Al-Lihaibi S.

Environ Sci Pollut Res Int. 2017 Jun;24(17):14657-14668. doi: 10.1007/s11356-017-8930-8. Epub 2017 Apr 28.

PMID:
28455569
7.

The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study.

Kılıç S, Çelik A, Çakmak HA, Afşin A, Tekkeşin Aİ, Açıksarı G, Memetoğlu ME, Özpamuk Karadeniz F, Şahan E, Alıcı MH, Dereli Y, Sinan ÜY, Zoghi M.

Balkan Med J. 2017 Apr 6. doi: 10.4274/balkanmedj.2016.1617. [Epub ahead of print]

8.

[New oral anticoagulants in patients with atrial fibrillation: efficacy and safety data from the real world].

Riva L, Di Pasquale G.

G Ital Cardiol (Rome). 2017 Mar;18(3):188-198. doi: 10.1714/2674.27396. Italian.

PMID:
28398377
9.

Edoxaban: How Does the Newest Agent Fit into the DOAC Landscape?

Gibson CM, Finks SW.

Am J Med. 2017 Apr 6. pii: S0002-9343(17)30342-X. doi: 10.1016/j.amjmed.2017.02.048. [Epub ahead of print] Review.

PMID:
28390791
10.

Integrating in vitro, modeling, and in vivo approaches to investigate warfarin bioequivalence.

Zhang X, Wen H, Fan J, Vince B, Li T, Gao W, Kinjo M, Brown J, Sun W, Jiang W, Lionberger R.

CPT Pharmacometrics Syst Pharmacol. 2017 Apr 5. doi: 10.1002/psp4.12198. [Epub ahead of print]

11.

[The Choice of Anticoagulant Therapy in Patients With Non-Valvular Atrial Fibrillation and Chronic Kidney Disease].

Koziolova NA, Polyanskaya EA, Kolegova II.

Kardiologiia. 2017 Jan;(1):76-85. Russian.

PMID:
28290837
12.

The Binding of Silibinin, the Main Constituent of Silymarin, to Site I on Human Serum Albumin.

Yamasaki K, Sato H, Minagoshi S, Kyubun K, Anraku M, Miyamura S, Watanabe H, Taguchi K, Seo H, Maruyama T, Otagiri M.

Biol Pharm Bull. 2017;40(3):310-317. doi: 10.1248/bpb.b16-00790.

13.

Laboratory Assessment of Direct Oral Anticoagulants.

Douxfils J, Gosselin RC.

Semin Thromb Hemost. 2017 Apr;43(3):277-290. doi: 10.1055/s-0036-1597296. Epub 2017 Mar 1. Review.

PMID:
28249326
14.

Non-Pharmacologic Approach to Prevent Embolization in Patients with Atrial Fibrillation in Whom Anticoagulation is Contraindicated.

Sharma M, Khalighi K.

Clin Pract. 2017 Jan 18;7(1):898. doi: 10.4081/cp.2017.898. eCollection 2017 Jan 11.

15.

Assessment of novel oral anticoagulant use within a community teaching hospital.

Alghadeer S, Hornsby L.

Saudi Pharm J. 2017 Jan;25(1):93-98. doi: 10.1016/j.jsps.2016.02.002. Epub 2016 Feb 15.

16.

Substitution at the C-3 Position of Catechins Has an Influence on the Binding Affinities against Serum Albumin.

Ikeda M, Ueda-Wakagi M, Hayashibara K, Kitano R, Kawase M, Kaihatsu K, Kato N, Suhara Y, Osakabe N, Ashida H.

Molecules. 2017 Feb 18;22(2). pii: E314. doi: 10.3390/molecules22020314.

17.

Managing patients taking edoxaban in dentistry.

Curto A, Curto D, Sanchez J.

J Clin Exp Dent. 2017 Feb 1;9(2):e308-e311. doi: 10.4317/jced.53431. eCollection 2017 Feb. Review.

18.

Old and new oral anticoagulants: Food, herbal medicines and drug interactions.

Di Minno A, Frigerio B, Spadarella G, Ravani A, Sansaro D, Amato M, Kitzmiller JP, Pepi M, Tremoli E, Baldassarre D.

Blood Rev. 2017 Feb 5. pii: S0268-960X(16)30035-2. doi: 10.1016/j.blre.2017.02.001. [Epub ahead of print] Review.

19.

Comparison of the safety and efficacy between 3-factor and 4-factor prothrombin complex concentrates for the reversal of warfarin.

Kuroski JE, Young S.

Am J Emerg Med. 2017 Jan 24. pii: S0735-6757(17)30066-9. doi: 10.1016/j.ajem.2017.01.049. [Epub ahead of print]

PMID:
28161220
20.

Determination of rodenticides and related metabolites in rabbit liver and biological matrices by liquid chromatography coupled to Orbitrap high resolution mass spectrometry.

López-García M, Romero-González R, Frenich AG.

J Pharm Biomed Anal. 2017 Apr 15;137:235-242. doi: 10.1016/j.jpba.2017.01.043. Epub 2017 Jan 28.

PMID:
28160742

Supplemental Content

Loading ...
Support Center